Polysynth Pharmaceuticals Mfg Co Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.65 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 1.90 M
About Polysynth Pharmaceuticals Mfg Co
Polysynth Pharmaceuticals Mfg Co Private Limited (PPMCPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 2005 and has a history of 19 years and five months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.65 M.
The company currently has active open charges totaling ₹1.90 M.
Dipendra Sinha and Payel Sinha serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239WB2005PTC105387
- Company No.
105387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2005
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Polysynth Pharmaceuticals Mfg Co?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipendra Sinha  | Director | 14-Sep-2005 | Current |
| Payel Sinha | Director | 14-Sep-2005 | Current |
Financial Performance of Polysynth Pharmaceuticals Mfg Co.
Enhance accessibility to Polysynth Pharmaceuticals Mfg Co's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Polysynth Pharmaceuticals Mfg Co?
In 2016, Polysynth Pharmaceuticals Mfg Co had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.90 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Bikaner & Jaipur : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Apr 2007 | State Bank Of Bikaner & Jaipur | ₹1.90 M | Open |
How Many Employees Work at Polysynth Pharmaceuticals Mfg Co?
Unlock and access historical data on people associated with Polysynth Pharmaceuticals Mfg Co, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polysynth Pharmaceuticals Mfg Co, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polysynth Pharmaceuticals Mfg Co's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.